Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Matinas Biopharma Holdings Inc | MTNB | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.0092 | 0.58% | 1.5892 | 1.61 | 1.52 | 1.61 | 1.58 | 11:44:26 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,045 | 615,948 | $ 1.58 | $ 971,037 | 2,397,907 | 0.501 - 2.18 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:44:26 | 3,100 | $ 1.5892 | USD |
Matinas Biopharma Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 258.63M | 162.74M | $ -14.08M | -0.15 | - | 152.11M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 5.04M | $ - | 0.00% | 26.00 | 6.50% |
Matinas Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MTNB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.60 | 2.18 | 1.49 | 1.78 | 5,200,516 | -0.0108 | -0.68% |
| 1 Month | 1.10 | 2.18 | 0.9802 | 1.44 | 3,966,281 | 0.4892 | 44.47% |
| 3 Months | 0.60 | 2.18 | 0.5818 | 1.30 | 1,682,542 | 0.9892 | 164.87% |
| 6 Months | 0.81 | 2.18 | 0.5818 | 1.14 | 1,091,023 | 0.7792 | 96.2% |
| 1 Year | 0.80 | 2.18 | 0.501 | 1.10 | 1,056,399 | 0.7892 | 98.65% |
| 3 Years | 3.99 | 4.35 | 0.3237 | 1.12 | 832,895 | -2.40 | -60.17% |
| 5 Years | 3.99 | 4.35 | 0.3237 | 1.12 | 832,895 | -2.40 | -60.17% |
Matinas Biopharma Description
| Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. Its lead anti-fungal product candidate, MAT2203, safely and effectively delivers anti-infective therapies utilizing its proprietary LNC formulation technology. In addition, it is pursuing the development of MAT9001 which is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, which has shown superiority versus Vascepa (icosapent ethyl) in reducing serum triglycerides, Total- and Non-HDL-Cholesterol, apolipoproteins, and PCSK9 levels. |
